Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma in patients with metastatic disease. Researchers from Dana-Farber Cancer Institute report a response rate of 24 percent across all risk categories of patients given an oral first-in-class agent that targets hypoxia inducible factor (HIF) 2-a, which promotes… Read More »
Researchers at the University of Georgia have developed a microfluidic chip to isolate circulating tumor cells (CTCs) from blood samples. Unlike other devices, this new chip uses magnetic microbeads to strip all the cells from the blood, leaving only the CTCs, in a technique the researchers have called “integrated ferrohydrodynamic cell separation”. The device is… Read More »
Wesley Lacey, 28, with his son Jack, said that they initially believed the boy’s crooked smile was an imitation of someone else. (Caters News Agency) The heartbroken parents of a 3-year-old boy in the U.K. said that when they noticed that their son was flashing a new, crooked smile they simply thought that maybe he was… Read More »